Literature DB >> 4146020

Modification of severe graft-versus-host disease with antisera to the (theta) antigen or to whole serum.

M L Tyan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4146020     DOI： 10.1097/00007890-197306000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  3 in total

Review 1.  Target cells in graft-versus-host disease: implications for cancer therapy.

Authors:  George F Murphy
Journal:  Clin Rev Allergy Immunol       Date:  2007-08-14       Impact factor: 8.667

2.  Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin.

Authors:  D A Vallera; R J Youle; D M Neville; J H Kersey
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

3.  Gamma irradiation preserves immunosuppressive potential and inhibits clonogenic capacity of human bone marrow-derived mesenchymal stromal cells.

Authors:  Ana Valéria Gouveia de Andrade; Julia Riewaldt; Rebekka Wehner; Marc Schmitz; Marcus Odendahl; Martin Bornhäuser; Torsten Tonn
Journal:  J Cell Mol Med       Date:  2014-03-21       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.